None
Quote | Seelos Therapeutics Inc. (NYSE:SEEL)
Last: | $ |
---|---|
Change Percent: | 2.60% |
Open: | $0.79 |
Close: | $0.79 |
High: | $0.8382 |
Low: | $0.78 |
Volume: | 966,621 |
Last Trade Date Time: | 02/12/2020 04:39:52 pm |
News | Seelos Therapeutics Inc. (NYSE:SEEL)
Scientific interest in psychedelics has increased greatly over the past few years as more and more trials determine that these substances possess the therapeutic potential to treat disorders such as post traumatic stress disorder (PTSD), depression or anxiety. Substances with the most promisin...
2024-06-14 16:20:20 ET Seelos Therapeutics ( NASDAQ: SEEL ) files to sell 924K shares of common stock for holders. This preliminary prospectus is not an offer to sell. SEC Filing Read the full article on Seeking Alpha For further details see: See...
Message Board Posts | Seelos Therapeutics Inc. (NYSE:SEEL)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SEEL News Article - Review Examines Trials on Use of Psychedelics by Older Adults | whytestocks | investorshangout | 04/24/2023 6:55:46 PM |
whytestocks: $SEEL News Article - Seelos Therapeutics Doses the First Amyotrophic Lateral Sclerosis | whytestocks | investorshangout | 04/04/2023 4:20:47 PM |
whytestocks: $SEEL News Article - Is Now the Time for Insurers, Employers to Cover Psychedelic Treat | whytestocks | investorshangout | 03/10/2023 5:30:47 PM |
whytestocks: $SEEL News Article - Seelos Therapeutics to Participate in 43rd Annual Cowen Health Car | whytestocks | investorshangout | 02/15/2023 4:25:47 PM |
whytestocks: $SEEL News Article - Seelos Therapeutics Doses First Patients in an Ethnobridging Study | whytestocks | investorshangout | 02/06/2023 1:11:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Seelos Therapeutics Inc. Company Name:
SEEL Stock Symbol:
NYSE Market:
Seelos Therapeutics Inc. Website:
Scientific interest in psychedelics has increased greatly over the past few years as more and more trials determine that these substances possess the therapeutic potential to treat disorders such as post traumatic stress disorder (PTSD), depression or anxiety. Substances with the most promisin...
A number of companies involved in the psychedelic space saw their stocks plummet during premarket trading earlier this week after an advisory panel counseled the U.S. Food and Drug Administration (FDA) against approving the use of MDMA as a treatment for post traumatic stress disorder (PTSD). ...
A recently conducted analysis has determined that people who had used psychedelics at some point in their lives experienced less psychological distress. The analysis also revealed that this link was highest in single people and significantly reduced in individuals who were married, divorced o...